HSDT
Helius Medical Technologies Inc Class A
NASDAQ: HSDT · FINANCIAL SERVICES · ASSET MANAGEMENT
$2.39
-7.50% today
Updated 2026-06-03
Market cap
$74.15M
P/E ratio
0.00
P/S ratio
7.73x
EPS (TTM)
$379.14
Dividend yield
—
52W range
$1 – $93
Volume
0.4M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A6.5
Quality
B2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$3.50
+46.44%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 7,290.00% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-4.83M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $787000.00 | $644000.00 | $520000.00 | $6.02M | $9.59M |
| Net income | $-14.07M | $-8.85M | $-11.74M | $-40.89M | $-99.80M |
| EPS | — | — | — | — | $379.14 |
| Free cash flow | $-14.33M | $-10.45M | $-11.05M | $-61.29M | $-4.83M |
| Profit margin | -1,788.06% | -1,374.22% | -2,258.08% | -679.57% | — |
Peer comparison
Smart narrative
Helius Medical Technologies Inc Class A trades at $2.39. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $9.59M.
Frequently asked questions
What is Helius Medical Technologies Inc Class A's stock price?
Helius Medical Technologies Inc Class A (HSDT) trades at $2.39, on a P/S of 7.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Helius Medical Technologies Inc Class A overvalued?
Helius Medical Technologies Inc Class A carries a Smart Value Score of 37/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Helius Medical Technologies Inc Class A (HSDT)?
The 12-month analyst consensus target is $3.50, about 46.4% above the current $2.39. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Helius Medical Technologies Inc Class A's revenue?
Helius Medical Technologies Inc Class A's trailing twelve-month revenue is $9.59M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorFINANCIAL SERVICES
IndustryASSET MANAGEMENT
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio7.73x
ROE-137.40%
Beta1.07
50D MA$2.05
200D MA$4.98
Shares out0.06B
Float0.04B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—